Unsurprisingly strong Q2 21
21/07/21 -"Sartorius announced expected Q2/H1 21 earnings, which had little element of surprise following the preliminary announcement on 6 July. H1 sales (+60.1%), EBITDA margins (34.1%) as well as guidance ..."
Pages
59
Language
English
Published on
21/07/21
You may also be interested by these reports :
30/07/21
The pandemic seems to have revealed all the oddities in FMC’s business model, which usually benefits from the continued inflow of new patients. Here ...
30/07/21
Benefiting from the strong market recovery, EssilorLuxottica witnessed an acceleration in sales in Q2 with optical growing faster than the sun ...
30/07/21
Back in March 2018 when Healthineers (Reduce, Germany) was given birth by way of an IPO, there was only muted enthusiasm about yet another Siemens ...
29/07/21
Smith & Nephew reported consensus beating Q2 21 sales growth of 40.3%, thanks to a strong recovery in Orthopaedics (+43.4%) and ‘sports medicine & ...